What notation is required on the face of a C-II prescription for a terminally ill patient?

For a prescription for a Schedule II controlled substance issued for a terminally ill patient, it is essential that the prescription clearly notes either 'terminally ill' or 'LTCF patient' (Long-Term Care Facility patient). This notation is important because it distinguishes these prescriptions from standard prescriptions and reflects the specific considerations that apply to patients who are terminally ill, including the urgency and management of their pain and symptoms.

This requirement aligns with federal regulations that allow for certain flexibilities in the dispensing of controlled substances for patients who are terminally ill or residing in long-term care facilities, ensuring that their care needs are prioritized. The notation aids pharmacists in recognizing that these patients might require different handling of their medication to accommodate their unique healthcare circumstances.

The other options do not accurately reflect the specific requirements for C-II prescriptions for terminally ill patients. For example, 'emergency use' denotes a different context not relevant to this scenario, while referencing the patient's doctor does not replace the critical required notation about the patient's condition. Lastly, it is incorrect to say that no special notation is needed, as that would overlook the regulations set in place to ensure appropriate care for this vulnerable patient population.